The HMRI Cancer Research Program (CRP) was formally established in 2002 to bring together the various basic science and clinical researchers in the Hunter to achieve common goals in the fight against cancer. Bringing together basic science and clinical researchers, the Cancer Research Program aims to reduce the incidence of cancer and to create effective therapies by tailoring treatments to the genetic profile of the disease, and to individual patients’ needs. From understanding the biology of cancer and developing more effective cancer therapies, through to evaluating therapies through clinical trials, researchers are aiming to reduce the impact of cancer in our community.
Researchers, students and support staff: 150 members from the University of Newcastle, Hunter New England Health and Calvary Mater Newcastle Hospital, united by the common goal to prevent and find more effective treatments for cancer.
The Program includes biomedical, clinical and public health researchers who are working across specialty research groups, including cancer genetics, cellular and molecular oncology, anti-cancer therapies, cancer trials, psycho-oncology for cancer patients and carers, and health behaviours to reduce the risk of developing cancer.
HMRI’s cancer research is focused on five key malignancies:
The Cancer Research Program is made up of multidisciplinary teams of scientists, clinicians and statisticians working to improve our understanding of cancer and how to better prevent and treat the disease.
The Program also incorporates two national clinical trials groups based in the Hunter:
Australian New Zealand Breast Cancer Trials Group
Trans-Tasman Radiation Oncology Group
HMRI Research Programs receive infrastructure funding from the NSW Office for Medical Research through the Medical Research Support Program, and the NSW Department of Health through the Capacity Building Infrastructure Grant Program. This funding supports essential research infrastructure, including research salaries, research equipment and technology services.
University of Newcastle Priority Research Centre in Cancer
The strength of cancer research in the Hunter was recently recognised by the University of Newcastle through the establishment of a Priority Research Centre in Cancer. The core aims, objectives and committees of the CRP have fundamentally merged with those of the PRC. Many members of the HMRI Cancer Research Program are also affiliated with the Priority Research Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine.